Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000152351 | SCV000114393 | likely benign | not specified | 2017-07-05 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000152351 | SCV000201263 | benign | not specified | 2018-04-18 | criteria provided, single submitter | clinical testing | p.Ala12450Val in exon 193 of TTN: This variant is classified as benign because i t has been identified in 0.5% (198/34230) of Latino chromosomes by the Genome Ag gregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs72677221) . ACMG/AMP Criteria applied: BA1. |
Gene |
RCV001704007 | SCV000237180 | likely benign | not provided | 2020-12-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28771489) |
Labcorp Genetics |
RCV000474807 | SCV000555216 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000152351 | SCV000616087 | benign | not specified | 2017-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618391 | SCV000736568 | likely benign | Cardiovascular phenotype | 2016-04-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001839883 | SCV002100700 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839884 | SCV002100701 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839885 | SCV002100702 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839882 | SCV002100703 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152351 | SCV004038624 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704007 | SCV004152419 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | TTN: BS1 |
Breakthrough Genomics, |
RCV001704007 | SCV005259514 | likely benign | not provided | criteria provided, single submitter | not provided |